Prescription of potentially inappropriate medications after an intensive care unit stay for acute respiratory failure

Somnath Bose(Prime University), Mustafa Mir-Kasimov(George E. Wahlen Department of VA Medical Center), Danielle Groat(Intermountain Medical Center), James C. Jackson(Vanderbilt University), Carla M. Sevin(Vanderbilt University), Samuel M. Brown(University of Utah), Joanna L. Stollings(Vanderbilt University Medical Center), Victor D. Dinglas(Johns Hopkins University), Harris Carmichael(Intermountain Medical Center), Dale M. Needham(Johns Hopkins University), Valerie Banner‐Goodspeed(Beth Israel Deaconess Medical Center), Patrick Barney(Vanderbilt University)
Australian Critical Care
April 29, 2024
10.1016/j.aucc.2024.02.001
Cited by 1

Related Papers

Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial
|The Lancet|2008|2k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Long-Term Cognitive Impairment After Critical Illness
|Survey of Anesthesiology|2014|1.1k
An Official American Thoracic Society Clinical Practice Guideline: The Diagnosis of Intensive Care Unit–acquired Weakness in Adults
|American Journal of Respiratory and Critical Care Medicine|2014|531
Effect of Titrating Positive End-Expiratory Pressure (PEEP) With an Esophageal Pressure–Guided Strategy vs an Empirical High PEEP-F <scp>io</scp> <sub>2</sub> Strategy on Death and Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome
|JAMA|2019|468